Structures by: Shripanavar C. S.
Total: 14
(<i>Z</i>)-<i>N</i>'-[(<i>E</i>)-4-Methoxybenzylidene]-2-(methoxyimino)-2-{2-[(2-methylphenoxy)methyl]phenyl}acetohydrazide
C25H25N3O4
IUCrData (2020) 5, 8 x201060
a=7.8041(6)Å b=22.8879(16)Å c=25.2670(16)Å
α=90° β=90° γ=90°
(2<i>E</i>)-2-Methoxyimino-2-{2-[(2-methylphenoxy)methyl]phenyl}-<i>N</i>'-(4-nitrobenzylidene)ethanohydrazide
C24H22N4O5
Acta Crystallographica Section E (2015) 71, 4 377-379
a=7.6821(4)Å b=23.2151(12)Å c=25.1943(15)Å
α=90° β=95.803(2)° γ=90°
Ethyl 3-[(6-chloropyridin-3-yl)methyl]-2-oxoimidazolidine-1-carboxylate
C12H14ClN3O3
Acta Crystallographica Section E (2012) 68, 2 o469
a=13.3926(14)Å b=8.4991(8)Å c=12.3361(12)Å
α=90.00° β=106.538(10)° γ=90.00°
Poly[μ~2~-aqua-μ~4~-(2-{3-[(6-chloropyridin-3-yl)methyl]-2-oxoimidazolidin- 1-yl}acetato)-sodium]
C11H13ClN3NaO4
Acta Crystallographica Section E (2012) 68, 7 m891-m892
a=45.655(2)Å b=4.9113(2)Å c=12.5205(7)Å
α=90.00° β=102.184(5)° γ=90.00°
1-[(6-Chloropyridin-3-yl)methyl]imidazolidin-2-iminium chloride
C9H12ClN4,Cl
Acta Crystallographica Section E (2012) 68, 1 o147
a=6.4773(3)Å b=7.3091(3)Å c=12.4758(4)Å
α=88.996(3)° β=77.214(3)° γ=79.925(3)°
Ethyl 2-{3-[(6-chloropyridin-3-yl)methyl]-2-(nitroimino)imidazolidin-1-yl}acetate
C13H16ClN5O4
Acta Crystallographica Section E (2012) 68, 4 o987
a=7.8136(2)Å b=19.3483(4)Å c=10.1926(2)Å
α=90.00° β=100.346(2)° γ=90.00°
1-[(6-Chloropyridin-3-yl)methyl]imidazolidin-2-one
C9H10ClN3O
Acta Crystallographica Section E (2012) 68, 6 o1939
a=5.9864(3)Å b=7.4724(5)Å c=11.0235(8)Å
α=83.103(6)° β=80.040(5)° γ=80.020(5)°
2-[(<i>E</i>)-Methoxyimino]-2-{2-[(2-methylphenoxy)methyl]phenyl}ethanoic acid
C17H17NO4
Acta Crystallographica Section E (2012) 68, 8 o2425
a=7.8993(3)Å b=8.5720(3)Å c=12.6080(5)Å
α=88.013(3)° β=82.270(3)° γ=65.717(4)°
2-(Methoxyimino)-2-{2-[(2-methylphenoxy)methyl]phenyl}acetohydrazide
C17H19N3O3
Acta Crystallographica Section E (2012) 68, 8 o2426
a=21.4015(6)Å b=20.7277(4)Å c=7.6975(2)Å
α=90.00° β=109.103(3)° γ=90.00°
3-[(2-Chloro-1,3-thiazol-5-yl)methyl]-5-methyl-1,3,5-oxadiazinan-4-one
C8H10ClN3O2S
Acta Crystallographica Section E (2012) 68, 11 o3109
a=4.6141(2)Å b=11.7335(4)Å c=20.1460(8)Å
α=90.00° β=90.00° γ=90.00°
<i>N</i>-[2-({[1-(4-Chlorophenyl)-1<i>H</i>-pyrazol-3-yl]oxy}methyl)phenyl]- <i>N</i>-methoxyhydrazinecarboxamide
C18H18ClN5O3
Acta Crystallographica Section E (2012) 68, 10 o2916
a=7.6830(4)Å b=9.1597(4)Å c=26.1083(12)Å
α=90.00° β=91.683(4)° γ=90.00°
3-Methoxy-2-[2-({[6-(trifluoromethyl)pyridin-2-yl]oxy}methyl)phenyl]prop-\ 2-enoic acid
C17H14F3NO4
Acta Crystallographica Section E (2012) 68, 11 o3163
a=7.4701(4)Å b=10.1619(5)Å c=11.8219(5)Å
α=94.721(4)° β=100.079(4)° γ=110.685(5)°
2-Methoxyimino-2-{2-[(2-methylphenoxy)methyl]phenyl}ethanol
C17H19NO3
Acta Crystallographica Section E (2012) 68, 9 o2697
a=21.0394(14)Å b=20.4128(10)Å c=7.6711(5)Å
α=90.00° β=105.729(6)° γ=90.00°
5-((Methoxyimino){2-[(2-methylphenoxy)methyl]phenyl}methyl)-<i>N</i>-phenyl-1,3,4-oxadiazol-2-amine
C24H22N4O3
Acta Crystallographica Section E (2014) 70, 3 o357-o358
a=7.0629(4)Å b=12.5553(9)Å c=13.3705(11)Å
α=68.321(7)° β=83.678(6)° γ=78.567(6)°